Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl for prevention of sneezing during sedated nasal local anaesthetic injection
ACTRN12621000850875Phase 4Not yet recruiting
- Sponsor
- Portland District Health
- Start
- Jul 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fentanyl and propofol in Sneezing (3 arms), sponsored by Portland District Health. Primary endpoint: Incidence of inducing the sneeze reflex. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
fentanylpropofol
03
Conditions
Sneezing
Beyond the preview
Go deeper on ACTRN12621000850875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000850875.